Found 0 matching trials
A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer PHASE2 This was a randomized, placebo-controlled, double-blind study of vismodegib...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. PHASE2 A few studies have documented that some patients can be down-staged from an...
Show More Location
Rabin Medical Center
Learn More & Join Trial
Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC PHASE1 This study determine the maximal tolerate dose...
Location
Institut rΓ©ginal du Cancer de Montpellier
Learn More & Join Trial
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer PHASE2 This clinical trial evaluates the efficacy and safety of adding fecal micro...
Show More Location
Multiple Locations
Learn More & Join Trial
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy PHASE2 A comparison of prophylactic treatment with reactive treatment for skin tox...
Show More Location
Multiple Locations
Learn More & Join Trial
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases PHASE2 This is a multicentre, open-label, parallel-group, phase II-III, superiorit...
Show More Status
Active Not Recruiting
Location
Ziekenhuis Oost-Limburg
Learn More & Join Trial
A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis PHASE2 Though surgical resection remains the primary choice for advanced rectal ca...
Show More Learn More & Join Trial
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy PHASE2 The goal of this clinical trial is to help learn about the safety and feasi...
Show More Location
University of Kentucky
Learn More & Join Trial
Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer PHASE2 TORCH-M is a prospective, single-arm, two-cohort, investigator-initiated ph...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver PHASE2 The purpose of this study is to see if patients treated with both regional ...
Show More Location
Memorial Sloan Kettering Basking Ridge
Learn More & Join Trial